reviewThe Lancet OncologyJul 26, 2016Closed access

International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

Mayo Clinic in Arizona · Clinica Universidad de Navarra · +24 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

2,959
total citations
FWCI
120.16
Percentile
100%
References
124
Citations per year

Authors

40

Topics & keywords

Keywords
  • Multiple myeloma
  • Minimal residual disease
  • Medicine
  • Bone marrow
  • Myeloma protein
  • Clinical trial
  • Disease
  • Oncology
No related works found for this paper.